| ASC618 Gene Therapy in Hemophilia A Patients (NCT04676048) | ASC Therapeutics | 2022-08-03 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASC61in Subjects With Advanced Solid Tumors (NCT05287399) | Ascletis Pharmaceuticals Co., Ltd. | 2022-08-02 |
| A Study to Evaluate Pharmacokinetic/Pharmacodynamic Drug-drug Interaction and Safety/Tolerability Between RLD2202 and RLD2203 (NCT05481307) | Hanmi Pharmaceutical Company Limited | 2022-08-02 |
| Evaluate the Safety and Efficacy of ADGRE2 CAR-T in Patients With R/R AML (NCT05463640) | Zhejiang University | 2022-08-02 |
| A Study of a Psilocybin Analog (CYB003) in Healthy Participants With and Without Major Depressive Disorder (NCT05385783) | Cybin IRL Limited | 2022-08-02 |
| Testing the Combination of the Anticancer Drugs ZEN003694 and Binimetinib in Patients With Advanced/Metastatic or Unresectable Solid Tumors With RAS Alterations and Triple Negative Breast Cancer (NCT05111561) | National Cancer Institute (NCI) | 2022-08-02 |
| Study of SHR-8068 Combined With Adebrelimab and Bevacizumab in the Treatment of Advanced Hepatocellular Carcinoma (NCT05444088) | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2022-08-02 |
| A Study to Learn How Safe and Tolerable Vonsetamig is in Adult Patients With Chronic Kidney Disease (CKD) Who Need Kidney Transplantation and Are Highly Sensitized to Human Leukocyte Antigen (HLA) (NCT05092347) | Regeneron Pharmaceuticals | 2022-08-02 |
| Evaluate the Safety and Efficacy of CD33 CAR-T in Patients With R/R AML (NCT05473221) | Zhejiang University | 2022-08-02 |
| A Study to Investigate 14C-bemcentinib in Healthy Male Subjects (NCT06469138) | BerGenBio ASA | 2022-08-02 |
| Evaluate the Safety and Efficacy of CLL1+CD33 CAR-T in Patients With R/R AML (NCT05467254) | Zhejiang University | 2022-08-02 |
| A Study to Evaluate the Safety and Tolerability of BMS-986408 Alone and in Combination With Nivolumab or Nivolumab and Ipilimumab in Participants With Advanced Solid Tumors (NCT05407675) | Bristol-Myers Squibb | 2022-08-02 |
| Assess Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BAT8009 (NCT05405621) | Bio-Thera Solutions | 2022-08-02 |
| A Clinical Trial of XZP-3287 for Material Balance (NCT05478109) | Xuanzhu Biopharmaceutical Co., Ltd. | 2022-08-02 |
| The Effects of Mesenchymal Stem Cell Secretome in Lupus Patients (NCT05921058) | Universitas Sebelas Maret | 2022-08-01 |
| First in Human Study in Healthy Volunteers of Antimicrobial Peptide PL-18 Vaginal Suppositories (NCT05340790) | Protelight Pharmaceuticals Australia PTY LTD | 2022-08-01 |
| Mesenchymal Stem Cell Therapy for Knee Osteoarthritis (NCT05288725) | Next Generation Regenerative Medicine LLC | 2022-08-01 |
| Clinical Study of F61 Injection in Healthy Chinese Subjects (NCT05483504) | Wuhan Institute of Biological Products Co., Ltd | 2022-08-01 |
| A Dose Escalation Study of IBI324 in Subjects With Diabetic Macular Edema (NCT05489718) | Innovent Biologics (Suzhou) Co. Ltd. | 2022-08-01 |
| Study of 3D189 in Patients With Hematologic Malignancies (NCT05320809) | 3D Medicines | 2022-08-01 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Efficacy of Cisplatin Micelle Injection (HA132) in Patients With Advanced Malignant Solid Tumors (NCT05478785) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2022-08-01 |
| Processed Amniotic Fluid (pAF) for the Treatment of Chronic Wounds (NCT04438174) | University of Utah | 2022-08-01 |
| A Study of Intrapleural Administration of Bevacizumab and Camrelizumab for Malignant Pleural Effusion (NCT05330065) | The First Affiliated Hospital of Zhengzhou University | 2022-08-01 |
| Investigation of Oral OKN-007 in Recurrent High-grade Glioma Participants (NCT03649464) | Oblato, Inc. | 2022-08-01 |
| Study of Chemotherapy and PD-1 Inhibitor Combination With Anti-angiogenesis to Treat Elderly Lung Cancer (NCT05273814) | Tianjin Medical University Cancer Institute and Hospital | 2022-08-01 |
| Evaluate the Safety and Efficacy of CLL1 CAR-T in Patients With R/R AML (NCT05467202) | Zhejiang University | 2022-08-01 |
| A Clinical Study With Adalimumab Biosimilar (NCT06291948) | Laboratorios Richmond S.A.C.I.F. | 2022-08-01 |
| A Drug Interaction Study of Clarithromycin and LY3502970 in Healthy Participants (NCT05469126) | Eli Lilly and Company | 2022-08-01 |
| Imaging Biomarkers of Neuroplasticity and Neurodegeneration in the Living Human Brain (NCT05427656) | Thiel, Alexander, M.D. | 2022-08-01 |
| Relative Bioavailability Trial of Dapivirine Ring-004 and Ring-008 (NCT05416021) | International Partnership for Microbicides, Inc. | 2022-08-01 |
| Mesenchymal Stem Cells (MSCs) for Perianal Fistula (NCT05407766) | Ossium Health, Inc. | 2022-08-01 |
| Trauma-Focused Intervention With Women Experiencing Homelessness (NCT05873517) | Rush University Medical Center | 2022-08-01 |
| A Phase I First in Human Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of WGI-0301 in Patients With Advanced Solid Tumors (NCT05267899) | Zhejiang Haichang Biotech Co., Ltd. | 2022-08-01 |
| The Combination of Radiotherapy，Surufatinib and Sintilimab in High-Risk Localized Soft Tissue Sarcoma (NCT05839275) | Fudan University | 2022-08-01 |
| ITIL-168 in Advanced Solid Tumors (NCT05393635) | Instil Bio | 2022-08-01 |
| A Study to Understand How the Study Medicine (PF-07081532) is Processed in People With Liver Dysfunction (NCT05478603) | Pfizer | 2022-08-01 |
| Study to Evaluate Safety, Efficacy of Intralesional Injection of STP705 in Adults With Facial isSCC (NCT05421013) | Sirnaomics | 2022-08-01 |
| A Study to Evaluate Safety, Tolerability of Subcutaneous Injection in Adult Subjects Undergoing Abdominoplasty (NCT05422378) | Sirnaomics | 2022-08-01 |
| LYL273 for Patients With Relapsed or Refractory mCRC (NCT05319314) | Lyell Immunopharma, Inc. | 2022-08-01 |
| Phase I Clinical Study of Haplo-HSCT Combined With Hypoxic 3D-Cultured Umbilical Cord MSC for the Treatment of SAA (NCT07299123) | Chinese PLA General Hospital | 2022-08-01 |
| Effectivity and Safety of Combination Cream of Salicylic Acid, Aqua Posae Filiformis, Niacinamide, Lipohydroxy Acid, Procerad and Zinc PCA (NCT05497323) | Dr.dr.Irma Bernadette, SpKK (K) | 2022-08-01 |
| A Study of HS-10380 in Chinese Participants (NCT05480592) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2022-08-01 |
| B-Complex: A Nutraceutical SANS Countermeasure (NCT05366933) | National Aeronautics and Space Administration (NASA) | 2022-08-01 |
| Genetic Risk Stratification of Pediatric Skin Lesions (NCT05418959) | Massachusetts General Hospital | 2022-08-01 |
| Effects of Cannabis/Alcohol on Driving Performance and Field Sobriety Tests (NCT05273658) | University of California, San Diego | 2022-08-01 |
| TQ05105 Tablet for Myelofibrosis Treatment in Ruxolitinib-Resistant or Intolerant Patients (NCT06388759) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2022-08-01 |
| Dopaminergic Enhancement of Rehabilitation Therapy Early After Stroke (NCT05369533) | University of California, Los Angeles | 2022-08-01 |
| First-in-Human Study of GM-60106 in Healthy Adults and Otherwise Healthy Adults With an Increased Body Mass Index and Markers of Non-Alcoholic Fatty Liver Disease (NCT05517564) | JD Bioscience Inc. | 2022-08-01 |
| Pembrolizumab Plus CRT Followed by Surgery in Upper ESCC (NCT05541445) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2022-08-01 |
| Reducing African-American CVD Disparities Intervention Optimization (RADIO) Individuals on Statins (NCT05954000) | Northwell Health | 2022-08-01 |
| Safety and Efficacy of Autologous Transplantation of iPSC-RPE in the Treatment of Macular Degeneration (NCT05445063) | Beijing Tongren Hospital | 2022-08-01 |
| Exploratory Clinical Study of CD19-targeted CAR-T and CAR-DC in the Treatment of Relapsed and Refractory B-cell Lymphoma (NCT05585996) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2022-08-01 |
| Dorzagliatin and 1st Phase Insulin and Beta-cell Glucose Sensitivity in IGT and NGT (NCT05468229) | Chinese University of Hong Kong | 2022-08-01 |
| Furazolidone Quadruple Regimen Eradicate H. Pylori Infection (NCT06823791) | Liaocheng People's Hospital | 2022-08-01 |
| WMT for Recurrent Urinary Tract Infections (NCT07627412) | The Second Hospital of Nanjing Medical University | 2022-08-01 |
| Insulin Sensitizers Role in Control of PCOS Vicious Cycle. (NCT06170463) | Zagazig University | 2022-08-01 |
| Study of Maplirpacept (PF-07901801) in Combination With PLD in Patients With Platinum-Resistant Ovarian Cancer (NCT05261490) | Pfizer | 2022-08-01 |
| A Dose Escalation Study of HBI-2438 in Patients With Solid Tumors Harboring KRAS G12C Mutation (NCT05485974) | HUYABIO International, LLC. | 2022-08-01 |
| A Study on Pharmacokinetics and Safety of BAT2506 Injection Versus Simponi® (NCT05332730) | Bio-Thera Solutions | 2022-08-01 |
| hUC Mesenchymal Stem Cells (19#iSCLife®-UT) Therapy for Patients With Thin Endometrial Infertility (NCT05495711) | Sclnow Biotechnology Co., Ltd. | 2022-08-01 |
| A Dose Finding Study of CycloSam® Combined With External Beam Radiotherapy (NCT03612466) | Albert Einstein College of Medicine | 2022-08-01 |
| Study of Avutometinib (VS-6766) + Adagrasib in KRAS G12C NSCLC Patients (NCT05375994) | Verastem, Inc. | 2022-08-01 |
| The Effects of Mesenchymal Stem Cell Secretome in Rheumatoid Arthritis Patients (NCT05925647) | Universitas Sebelas Maret | 2022-08-01 |
| A Study of MAX-40279combined With KN046 in Patients With Advanced / Metastatic Solid Tumors (NCT05425602) | Maxinovel Pty., Ltd. | 2022-07-31 |
| A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM (NCT05303467) | Boston Scientific Corporation | 2022-07-30 |
| Single and Multiple Ascending Dose Study in Healthy Participants and Participants With an Autoimmune Disease (NCT06488209) | Almirall, S.A. | 2022-07-29 |
| A Phase 1/ 2, First-in-Human, Open-Label, Accelerated-Titration, Two-Part Clinical Trial of TK-8001 in Patients With HLA-A*02:01 Genotype and Advanced-Stage/ Metastatic MAGE-A1+ Solid Tumors (NCT05430555) | T-knife GmbH | 2022-07-29 |
| A Clinical Study of ICP-488 in Healthy Subjects and Patients With Psoriasis (NCT05451199) | Beijing InnoCare Pharma Tech Co., Ltd. | 2022-07-29 |
| First-in-Human Study to Assess the Safety, Tolerability and Pharmacokinetics of MMV367 (NCT05507970) | Medicines for Malaria Venture | 2022-07-29 |
| Clinical Trial of the TQB3602 Capsule Combined With AK105 Injection in Patients With Advanced Cancers (NCT05333276) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2022-07-29 |
| Study to Assess the Lung Exposure Bioequivalence of Budesonide, Glycopyrronium, and Formoterol Delivered by BGF MDI With Next-Generation Propellant Compared With BGF MDI With HFA Propellant (NCT05477108) | AstraZeneca | 2022-07-29 |
| A Study of Bisantrene Combined With Cytarabine or With Decitabine for Adult Subjects With Extramedullary AML and MDS (NCT05456269) | Racura Oncology Ltd | 2022-07-29 |
| A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 with Valganciclovir (VGCV) in Subjects with Hepatocellular Carcinoma (NCT05595473) | Rznomics, Inc. | 2022-07-29 |
| PK of CHF6001 in Subjects With Mild, Moderate and Severe Renal Impairment vs. Healthy Volunteers (NCT05431426) | Chiesi Farmaceutici S.p.A. | 2022-07-29 |
| CONFOCAL-2 Interventional Pilot Study (NCT07296029) | Queen's University | 2022-07-29 |
| A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer (NCT05379595) | Janssen Research & Development, LLC | 2022-07-29 |
| A Phase 1 Study of ONO-2020 in Healthy Participants (NCT05507515) | Ono Pharmaceutical Co., Ltd. | 2022-07-29 |
| Cebranopadol Effects on Ventilatory Drive, Central Nervous System (CNS) and Pain. (NCT05491785) | Tris Pharma, Inc. | 2022-07-29 |
| An Open Label Study That Will Test Safety and Efficacy of RZL-012 Injection Into the Submental Fat in Chinese vs. Non-Chinese Subjects. (NCT05466448) | Raziel Therapeutics Ltd. | 2022-07-29 |
| Navitoclax, Venetoclax, and Decitabine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Previously Treated With Venetoclax (NCT05222984) | City of Hope Medical Center | 2022-07-29 |
| The Effect of Micro Fragmented Adipose Tissue (MFAT) on Shoulder Osteoarthritis (NCT04929951) | Stanford University | 2022-07-28 |
| A Phase I Clinical Study of Recombinant Humanized Anti-BTLA Monoclonal Antibody (JS004) Injection Combined With Toripalimab Injection in Patients With Advanced Solid Tumors (NCT05427396) | Shanghai Junshi Bioscience Co., Ltd. | 2022-07-28 |
| Food Effects on Bioavailability of MDMA in Healthy Volunteers (NCT05147402) | Resilient Pharmaceuticals | 2022-07-28 |
| Butyrate Adjuvant Therapy for Type 1 Diabetes (NCT03999853) | Mayo Clinic | 2022-07-28 |
| A Phase 1 Study to Assess the Effect of Hepatic Impairment on the Pharmacokinetics of Repotrectinib in Advanced Cancer Patients (NCT05828277) | Turning Point Therapeutics, Inc. | 2022-07-28 |
| BI-1607 in Combination with Trastuzumab in Subjects with HER2-positive Advanced Solid Tumors (NCT05555251) | BioInvent International AB | 2022-07-28 |
| Testing of Tazemetostat in Combination With Topotecan and Pembrolizumab in Patients With Recurrent Small Cell Lung Cancer (NCT05353439) | National Cancer Institute (NCI) | 2022-07-27 |
| Study of Relatlimab in Combination With Nivolumab in Chinese Participants (NCT05498480) | Bristol-Myers Squibb | 2022-07-27 |
| Acute Pharmacokinetic and Pharmacodynamic Effects of "Tobacco-Free" Oral Nicotine Pouches in Smokers (NCT05335915) | Johns Hopkins University | 2022-07-27 |
| Drug-drug Interactions Between AZD4205 and Itraconazole/Carbamazepine (NCT05486949) | Dizal Pharmaceuticals | 2022-07-27 |
| To Evaluate the Safety and Tolerability of SYHX2001 in Patients With Advanced or Metastatic Solid Tumors (NCT05407909) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2022-07-27 |
| A Study to Assess the Effect of Oral Belumosudil on Inhibition of Various Proteins in the Fed State in Healthy Male Subjects (NCT05806567) | Kadmon, a Sanofi Company | 2022-07-27 |
| HER2-specific Chimeric Antigen Receptor (CAR) T Cells for Children With Ependymoma (NCT04903080) | Children's Oncology Group | 2022-07-27 |
| Thoracic Neuromodulation for Diabetic Gastroparesis (NCT05273788) | Medical University of South Carolina | 2022-07-27 |
| A Study of STAR-0215 in Healthy Adult Participants (NCT05477160) | Astria Therapeutics, Inc. | 2022-07-27 |
| A Study of Combination Therapies With or Without Pembrolizumab (MK-3475) and/or Chemotherapy in Participants With Advanced Esophageal Cancer (MK-3475-06A) (NCT05342636) | Merck Sharp & Dohme LLC | 2022-07-27 |
| Nebulised BromAc in Healthy Volunteers (NCT05220605) | Mucpharm Pty Ltd | 2022-07-27 |
| Palliative Radiotherapy With Lurbinectedin in Patients With Extensive Stage Small Cell Lung Cancer (NCT05244239) | Emory University | 2022-07-27 |
| Advanced or Recurrent Solid Tumors Treated With SHetA2 (NCT04928508) | University of Oklahoma | 2022-07-27 |
| Study to Evaluate Efficacy and Safety of HH2853 in Relapsed/Refractory Peripheral T-cell Lymphoma (NCT06909877) | Haihe Biopharma Co., Ltd. | 2022-07-27 |